This section is where you can find referenced articles mentioned within our IBD LIVE broadcasts, view the recordings of the program and listen to previews of our music playlist!
Severe Post-Operative Crohn’s Disease with Multidisciplinary Abdominal Wall Reconstruction
(Presented by University of Vermont)
A Case of Stubborn Rectal Dysplasia
(Presented by University of Rochester)
April 23, 2026: Watch Recording
- Dye Chromoendoscopy Outperforms High-Definition White Light Endoscopy in Dysplasia Detection for Patients With Inflammatory Bowel Disease: An Updated Meta-Analysis of Randomized Controlled Trials
- Dysplasia detection using high-definition scopes with dye vs virtual chromoendoscopy in IBD: A meta-analysis of randomized clinical trials
- Optimal Dysplasia Detection and Management in IBD: Now and in the Future
April 16, 2026: Watch Recording
- The Utility of Patency Capsule in Patients With Crohn’s Disease
- Portal hypertension triggers local activation of inducible nitric oxide synthase gene in colonic mucosa
- Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study
- Portal hypertensive colopathy: endoscopic findings and the relation to portal pressure
- Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis
- Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks
April 9, 2026: Watch Recording
April 2, 2026: Watch Recording
March 26, 2026: Watch Recording
March 19, 2026: Watch Recording
March 12, 2026: Watch Recoding
- IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis
- Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn’s disease
- Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn’s Disease: A Descriptive Case Series
- Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Diseases
- AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- Fecal Diversion for Perianal Crohn Disease in the Era of Biologic Therapies: A Multicenter Study
- Systematic Review and Meta-analysis: Faecal Diversion for Management of Perianal Crohn’s Disease
- AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease
- Medline ® Abstract for Reference 56 of ‘Medical management of moderate to severe Crohn disease in adults’
- Janus Kinase Inhibitors for Inflammatory Bowel Disease: Concise Questions and Answers on Their Use in Clinical Practice
- Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula (2022)
- Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
- Risk factors for short bowel syndrome in patients with Crohn’s disease
- Factors affecting poor nutritional status after small bowel resection in patients with Crohn disease
- Systematic Review and Meta-analysis: Faecal Diversion for Management of Perianal Crohn’s Disease
- Long-term outcomes of ‘temporary’ defunctioning in patients with severe perianal Crohn’s disease
- American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection
March 5, 2026: Watch recording
| December 2025 |
|---|
December 6, 2025: Watch Recording
|
| August 2025 |
|---|
| August 21, 2025: Watch Recording |
August 14, 2025: Watch Recording
|
| August 7, 2025: Watch Recording |
| FEBRUARY 2025 |
|---|
February 27, 2024: Watch Recording
|
| February 20, 2025: Watch Recording |
| February 13, 2025: Watch Recording |
February 6, 2025: Watch Recording
|